Bloomberg Businessweek Weekend - April 4th, 2025
Bloomberg Businessweek
The Pharmaceutical Tug-of-War
This chapter examines the implications of recent government actions, such as tariffs and changes in the Department of Health and Human Services, on the pharmaceutical industry. It highlights the relationship between regulatory bodies like the FDA and the drug approval process, while addressing the ongoing uncertainties affecting drug development and public health. The discussion also sheds light on vaccination importance, industry challenges, and the differing impacts on large pharma versus generic manufacturers.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
